[Effectiveness of different chemotherapy regimens in newly detected patients with destructive pulmonary tuberculosis]. 1987

T O Omarov, and L B Shefer, and S V V'iushkova, and E Sh Abzharkenova

UI MeSH Term Description Entries
D007902 Length of Stay The period of confinement of a patient to a hospital or other health facility. Hospital Stay,Hospital Stays,Stay Length,Stay Lengths,Stay, Hospital,Stays, Hospital
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

T O Omarov, and L B Shefer, and S V V'iushkova, and E Sh Abzharkenova
June 1978, Problemy tuberkuleza,
T O Omarov, and L B Shefer, and S V V'iushkova, and E Sh Abzharkenova
January 1984, Problemy tuberkuleza,
T O Omarov, and L B Shefer, and S V V'iushkova, and E Sh Abzharkenova
January 1990, Problemy tuberkuleza,
T O Omarov, and L B Shefer, and S V V'iushkova, and E Sh Abzharkenova
July 1976, Problemy tuberkuleza,
T O Omarov, and L B Shefer, and S V V'iushkova, and E Sh Abzharkenova
January 1975, Problemy tuberkuleza,
T O Omarov, and L B Shefer, and S V V'iushkova, and E Sh Abzharkenova
February 1980, Vrachebnoe delo,
T O Omarov, and L B Shefer, and S V V'iushkova, and E Sh Abzharkenova
March 1974, Problemy tuberkuleza,
T O Omarov, and L B Shefer, and S V V'iushkova, and E Sh Abzharkenova
January 1986, Problemy tuberkuleza,
T O Omarov, and L B Shefer, and S V V'iushkova, and E Sh Abzharkenova
January 2004, Problemy tuberkuleza i boleznei legkikh,
T O Omarov, and L B Shefer, and S V V'iushkova, and E Sh Abzharkenova
April 1978, Sovetskaia meditsina,
Copied contents to your clipboard!